BioCentury
ARTICLE | Clinical News

Gleevec imatinib regulatory update

February 4, 2013 8:00 AM UTC

FDA approved an sNDA for Gleevec imatinib from Novartis to treat pediatric patients with newly diagnosed Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL) in combination with c...